ATE165349T1 - Ein 4-imidazolinon-derivat und deren verwendung als nmda-rezeptor-agonist - Google Patents

Ein 4-imidazolinon-derivat und deren verwendung als nmda-rezeptor-agonist

Info

Publication number
ATE165349T1
ATE165349T1 AT96402661T AT96402661T ATE165349T1 AT E165349 T1 ATE165349 T1 AT E165349T1 AT 96402661 T AT96402661 T AT 96402661T AT 96402661 T AT96402661 T AT 96402661T AT E165349 T1 ATE165349 T1 AT E165349T1
Authority
AT
Austria
Prior art keywords
receptor agonist
nmda receptor
imidazolinone derivative
imidazolinone
derivative
Prior art date
Application number
AT96402661T
Other languages
English (en)
Inventor
Alex Cordi
Jean-Michel Lacoste
Mark Millan
Valerie Audinot
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of ATE165349T1 publication Critical patent/ATE165349T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT96402661T 1995-12-21 1996-12-09 Ein 4-imidazolinon-derivat und deren verwendung als nmda-rezeptor-agonist ATE165349T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9515223A FR2742748B1 (fr) 1995-12-21 1995-12-21 Nouveau derive de 4-imidazolidinone, son procede de preparation et les compositions pharmaceutiques qui le contiennent

Publications (1)

Publication Number Publication Date
ATE165349T1 true ATE165349T1 (de) 1998-05-15

Family

ID=9485771

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96402661T ATE165349T1 (de) 1995-12-21 1996-12-09 Ein 4-imidazolinon-derivat und deren verwendung als nmda-rezeptor-agonist

Country Status (14)

Country Link
US (1) US5677325A (de)
EP (1) EP0780379B1 (de)
JP (1) JPH09176128A (de)
CN (1) CN1067381C (de)
AT (1) ATE165349T1 (de)
AU (1) AU705695B2 (de)
CA (1) CA2193310C (de)
DE (1) DE69600253T2 (de)
DK (1) DK0780379T3 (de)
ES (1) ES2118664T3 (de)
FR (1) FR2742748B1 (de)
NO (1) NO305753B1 (de)
NZ (1) NZ299984A (de)
ZA (1) ZA9610804B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6347197B1 (en) * 2000-10-20 2002-02-12 Lexmark International, Inc. Life determination in an oil web system
JP3891484B2 (ja) * 2002-09-05 2007-03-14 株式会社ノリタケカンパニーリミテド 電解質膜およびその膜を備えた燃料電池

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904681A (en) * 1987-12-01 1990-02-27 G. D. Searle & Co. D-cycloserine and its prodrugs as cognitive enhancers

Also Published As

Publication number Publication date
NO965445L (no) 1997-06-23
CA2193310A1 (fr) 1997-06-22
NO965445D0 (no) 1996-12-18
ZA9610804B (en) 1997-06-30
CN1158847A (zh) 1997-09-10
CA2193310C (fr) 2001-08-14
CN1067381C (zh) 2001-06-20
ES2118664T3 (es) 1998-09-16
AU7547996A (en) 1997-06-26
FR2742748A1 (fr) 1997-06-27
EP0780379A1 (de) 1997-06-25
DK0780379T3 (da) 1999-01-25
NO305753B1 (no) 1999-07-19
JPH09176128A (ja) 1997-07-08
DE69600253D1 (de) 1998-05-28
EP0780379B1 (de) 1998-04-22
DE69600253T2 (de) 1998-11-12
NZ299984A (en) 1997-11-24
US5677325A (en) 1997-10-14
FR2742748B1 (fr) 1998-01-30
AU705695B2 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
LV10864A (lv) Triazinu atvasinajumi to iegusanas panemiens un herbicids kas tos iesledz sevi ka aktivu ingredientu
AU7001596A (en) Compounds potentiating retinoid
PT776893E (pt) Compostos azaciclicos com actividade antagonista do receptor de taquiquinina; nk1 e nk2
NO904022L (no) Fremgangsmaate for fremstilling av nye n-aryl- og n-heteroarylamid- og -urinstoffderivater.
FI910583A0 (fi) Derivat av tiazolidin med diabetesmotverkande effekt, deras framstaellning och deras anvaendning.
FI974447A0 (fi) Semikarbatsonit, joilla on keskushermostoaktiivisuutta, ja niitä sisältävät farmaseuttiset valmisteet
ATE174915T1 (de) Benzylpiperidinderivate mit hoher affinität zu bindungsstellen von aminosäure-rezeptoren
ATE137744T1 (de) Anilidderivat
PT780372E (pt) Derivados do acido 3-amino-2-mercaptobenzoico e processos para a sua preparacao
ES2067044T3 (es) Acil-enzimas activados por la luz.
ES2122360T3 (es) Procedimiento para la obtencion de iminas alifaticas.
BR9203919A (pt) Processo para a preparacao de uma n-(aril)-1,2,4-triazolopirimidina-2-sulfonamida
IT1271026B (it) Derivati dell'acido b-amminopropionico ad attivita' fungicida
ATE165349T1 (de) Ein 4-imidazolinon-derivat und deren verwendung als nmda-rezeptor-agonist
ATE47857T1 (de) Substituierte 4-benzyl-piperazinyl-verbindungen.
DK0585014T3 (da) Fremgangsmåde til fremstilling af 2-(u)substituerede-4-alkylimidazoler
DE69119668D1 (de) Hemmungsstoff für Aldosereduktase
EP0296120A3 (en) Aryloxyphenyl ureas, isothio ureas and carbodiimides, their preparation and their use for the control of pests
ATE161263T1 (de) 2,4-diamino-1,3,5-triazinyl-6- phosphonsäurederivate
DK0722934T3 (da) Fremgangsmåde til fremstilling af i 5-stillingen substituerede 2-chlorpyridiner
DE69615570D1 (de) Verfahren zur herstellung von carbamoylmethylharnstoff-derivaten
ES2003830B3 (es) Procedimiento para fabricacion de derivados de imidazolil-metano
DE58908130D1 (de) Verfahren zur Herstellung von Pyrimidinderivaten.
FI941650A0 (fi) Uudet fluorikinolin-3-karboksyylihappojohdannaiset ja niiden valmistus
DK0533132T3 (da) Fremgangsmåde til oxidation af hydroxymethylpyridinderivater til pyridincarboxylsyrederivater

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee